ARS Pharmaceuticals, Inc (SPRY): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 22,5 US Dollar | 4 | 0 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 99.447.343 | 30,72 | 14,7 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name ARS Pharmaceuticals, Inc
Mitarbeiter 195
Handelsplatz NASDAQ
Ticker Symbol SPRY
IPO Datum 2020-12-04
Adresse 11682 El Camino Real, San Diego, CA, United States, 92130
Webseite https://ars-pharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Justin Chakma | Chief Business Officer |
| 2 | Mr. Donn Casale | CEO, President & Director |
| 3 | Dr. Robert Bell Ph.D. | Co-Founder & Chief Science Officer |
| 4 | Ms. Kathleen D. Scott CPA | Chief Financial Officer |
| 5 | Mr. Brian T. Dorsey M.S. | Chief Operating Officer |
| 6 | Mr. Alexander A. Fitzpatrick Esq. | Chief Legal Officer & Secretary |
| 7 | Mr. Daniel Relovsky | Senior Vice President of Marketing |
| 8 | Ms. Lynda Harris | Vice President of Human Resources |
| 9 | Mr. Eric Karas | Chief Commercial Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RA Capital Management, LLC | 10,92% | 45,40 Mio. USD |
| 2 | Rubric Capital Management LP | 8,59% | 35,70 Mio. USD |
| 3 | Orbimed Advisors LLC | 8,33% | 34,65 Mio. USD |
| 4 | Deerfield Management Co | 7,55% | 31,37 Mio. USD |
| 5 | BlackRock Inc | 5,34% | 22,20 Mio. USD |
| 6 | Tyro Capital Management LLC | 4,48% | 18,64 Mio. USD |
| 7 | Aberdeen Group PLC | 4,19% | 17,43 Mio. USD |
| 8 | SR ONE CAPITAL MANAGEMENT, LP | 4,04% | 16,77 Mio. USD |
| 9 | State Street Corp | 3,75% | 15,59 Mio. USD |
| 10 | Capital World Investors | 2,77% | 11,52 Mio. USD |
| 11 | Vanguard Capital Management, LLC | 2,57% | 10,67 Mio. USD |
| 12 | Millennium Management LLC | 2,41% | 10,04 Mio. USD |
| 13 | Janney Montgomery Scott LLC | 2,08% | 8,63 Mio. USD |
| 14 | UBS Group AG | 1,95% | 8,11 Mio. USD |
| 15 | Geode Capital Management, LLC | 1,71% | 7,10 Mio. USD |
| 16 | BOOTHBAY FUND MANAGEMENT, LLC | 1,61% | 6,69 Mio. USD |
| 17 | General American Investors Co Inc | 1,14% | 4,74 Mio. USD |
| 18 | Third Point, LLC | 1,01% | 4,18 Mio. USD |
| 19 | Peregrine Capital Management,LLC | 0,68% | 2,81 Mio. USD |
| 20 | Tejara Capital Ltd | 0,61% | 2,54 Mio. USD |